The anti-OPN monoclonal antibody AOM1 blocks the αvβ3 binding site as well as the thrombin cleavage site of OPN, thus effectively inhibiting OPN-αvβ3 integrin interaction and reducing cell migration in colon cancer [151]. This evidence concerns the gene SPP1 and malignant colon neoplasm.